BioNTech
rationale for selection of for pivotal phase trial | BioNTech
Company
Deck Type
Sector
Industry
Deck date
August 2020
Slide
20 of 28
Related slides by other companies
Ocuphire Pharma
Investor Day
January 2022
phase clinical trials data supporting the zeta trial | Ocuphire Pharma
Adagio Therapeutics
Investor Presentation
May 2023
ongoing phase trial of with initial data planned for | Adagio Therapeutics
Exscientia
Results
August 2023
elucidate phase ongoing in advanced solid identified to be further assessed in the trial | Exscientia
ATAI
Investor Presentation
April 2023
phase proof of concept trial design all subjects tid tid placebo trial status in data anticipated randomized week study of and patients with | ATAI
Other recent decks by BioNTech
See all presentations (12 decks)
Investor Presentation
August 2022
Results
August 2022
Investor Day
June 2022
Results
March 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights